New app aims to empower liver cirrhosis patients
NCT ID NCT06995196
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a smartphone app called ReLiver-N designed to help people with liver cirrhosis take a more active role in their care. The app provides health education, self-management tools, and a system to flag urgent issues. Researchers enrolled 48 patients with mild to moderate cirrhosis and randomly assigned them to use the full app or just the educational content. The goal was to see if the app improves patients' ability to manage their condition, their confidence, and their quality of life over 90 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ReLiver-N App (mobile health application with education, activation, and clinical decision support)
- What this could lead to
- If successful, this app could provide a low-cost, scalable way to help liver cirrhosis patients better manage their health and reduce hospital readmissions.
- What could go wrong
- This is a small, single-blind study with only 48 participants. The app's benefits may not be large or lasting, and results may not apply to all cirrhosis patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Akdeniz University
Antalya, Antalya, 07070, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- A new procedure may offer relief for Cirrhosis-Related fluid buildup
- Can liver damage predict how drugs behave?
- Better crystal ball for liver crisis: new scores put to the test
- Blood thinner may stop early cirrhosis from turning deadly — a major trial puts it to the test
- Stick-On ultrasound patch could spot liver damage without a specialist